About Index Trending news
Analyze
Pricing
Trevena

Trevena

Work at Trevena? Add yourself to this profile

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Edit Profile
More info

Elsewhere

Companies in the same industry

Nextrials Nextrials Podimetrics Podimetrics Achaogen Achaogen ScriptRx ScriptRx Ligand Ligand Catasys® Catasys® Genzum Life Sciences Genzum Life Sciences Catabasis Catabasis TriVascular TriVascular SingularityU SingularityU

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Latest funding Show all
Post-IPO equity
$45,000,000
Venture capital (Series C)
$60,000,000
Forest Laboratories
Employees

Team size

10+
Locations
Unknown
Help us complete this profile
The Motley Fool

Here's Why Trevena Stock Dropped 18% Today

Trevena
Trevena
The Motley Fool

Why Trevena Inc.'s Shares Broke Through Today

Health Stock markets
Trevena
Trevena